课题基金 / 基金详情

Randomized Trial of a Smoking Cessation Program for Persons with SMI

Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
批准号:
7916627
负责人:
LISA B. DIXON
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-10-01 至 2013-12-31
关键词:
AbstinenceAddressAftercareAmerican Lung AssociationAttentionBehavior TherapyBehavioralBiologicalBupropionCarbon MonoxideCategoriesCessation of lifeCharacteristicsCigaretteClinicClinical Practice GuidelineCocaineCognitiveCommunitiesDepartment of DefenseDiabetes MellitusDiagnosticDisabled PersonsDiseaseDrug usageEducationEffectivenessEnsureFaceFundingGeneral PopulationGoalsGrantGuidelinesHealthHealth Care CostsHealth care facilityHealthcareHealthcare SystemsHeart DiseasesHeroinImpairmentInterventionLifeMalignant neoplasm of lungMarylandMeasuresMedical EconomicsMental HealthMental disordersModelingMorbidity - disease rateNational Institute of Drug AbuseNicotine DependenceObesityOutcomeParticipantPatient Self-ReportPatientsPersonsPharmacotherapyPhasePoliciesPopulationProceduresPublic HealthRandomizedRandomized Clinical TrialsReadinessRecruitment ActivityReportingResearchSchizophreniaSeriesSeveritiesSmokeSmokerSmokingSmoking Cessation InterventionSocial supportSpecific qualifier valueSubstance AddictionSubstance Use DisorderSubstance abuse problemTechnologyTestingTobacco useUnited StatesUnited States Agency for Healthcare Research and QualityVeteransWithholding TreatmentWorkabstractingaddictionbasecigarette smokingcontingency managementcostdesignevidence basefollow-uphandicapping conditionhealth care qualityimprovedinnovationmeetingsmortalitynicotine replacementnovel strategiesoutreachprogramspsychologicpublic health relevancerandomized trialsmoking cessationsocialsocial modelsubstance abusertherapy developmenttooltreatment programtrial comparing

项目成果

LISA B. DIXON的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing Disability Benefit Decisions and Outcomes in First Episode Psychosis
Adapting Coordinated Specialty Care in the Post COVID-19 Era
海外基金